Comparing two endoscopic treatments for small rectal neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rectal neuroendocrine tumor (a slow-growing tumor in the rectum) diagnosed and scheduled for endoscopic removal
- Your tumor is smaller than 2 centimeters (about the size of a small bean)
- Imaging tests show no cancer spread to nearby lymph nodes or distant organs
- Your doctor plans to remove the tumor using either ESD (endoscopic submucosal dissection) or EPMR (endoscopic full-thickness resection)—two specific minimally invasive techniques
- You are willing to participate and your family supports your involvement
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive methods to remove small rectal neuroendocrine tumors (less than 1 cm) during a colonoscopy. It may help patients avoid major surgery while still effectively treating the tumor.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial compares two procedures to remove large, non-cancerous growths from the lower rectum. It aims to see which method is safer and more effective for patients with these specific types of growths.
This study looks at removing small rectal neuroendocrine tumors using an endoscope (a thin camera tool) instead of open surgery. It may help people with very small tumors if the doctors think you can safely have this procedure and the cancer has not spread to lymph nodes or distant organs.
This trial tests two endoscopic techniques (mEMR-C and mEMR-L) to remove small rectal neuroendocrine tumors. It may help patients with tumors 10 mm or smaller who want a less invasive treatment option.
This trial tests a new robotic system to remove large, flat growths in the rectum without traditional surgery. It may help people who have early-stage rectal tumors that are too big for standard removal methods.
Hear when a new Rectal Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.